Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Lawandi

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Microbiology Spectrum|September 30, 2025
The combinations of cefazolin with linezolid and cefazolin with clindamycin are indifferent against methicillin-susceptible <i>Staphylococcus aureus</i>Madeline Mellett, Julia Van Riel, Rachel Corsini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2024
Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US HospitalsKai Qian Kam, Tom Chen, Sameer S Kadri, et al.
Annals of Internal Medicine|April 19, 2024
Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals : A Retrospective Cohort StudyJeffrey R Strich, Ahmed Mishuk, Guoqing Diao, et al.
Annals of Internal Medicine|September 17, 2019
Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic StudyMatthew P Cheng, Robert Stenstrom, Katryn Paquette, et al.
Open Forum Infectious Diseases|July 26, 2021
Neither Blood Culture Positivity nor Time to Positivity Is Associated With Mortality Among Patients Presenting With Severe Manifestations of Sepsis: The FABLED Cohort StudyKatryn Paquette, David Sweet, Robert Stenstrom, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 3, 2023
qSOFA does not predict bacteremia in patients with severe manifestations of sepsisMatthew P Cheng, Katryn Paquette, Alexander Lawandi, et al.
Open Forum Infectious Diseases|October 2, 2020
Real-world Time to Positivity of 2 Widely Used Commercial Blood Culture Systems in Patients With Severe Manifestations of Sepsis: An Analysis of the FABLED StudyGuillaume Butler-Laporte, Cedric P Yansouni, Katryn Paquette, et al.
Annals of Internal Medicine|July 5, 2021
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020Sameer S Kadri, Junfeng Sun, Alexander Lawandi, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Microbiology Spectrum|September 30, 2025
The combinations of cefazolin with linezolid and cefazolin with clindamycin are indifferent against methicillin-susceptible <i>Staphylococcus aureus</i>Madeline Mellett, Julia Van Riel, Rachel Corsini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2024
Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US HospitalsKai Qian Kam, Tom Chen, Sameer S Kadri, et al.
Annals of Internal Medicine|April 19, 2024
Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals : A Retrospective Cohort StudyJeffrey R Strich, Ahmed Mishuk, Guoqing Diao, et al.
Annals of Internal Medicine|September 17, 2019
Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic StudyMatthew P Cheng, Robert Stenstrom, Katryn Paquette, et al.
Open Forum Infectious Diseases|July 26, 2021
Neither Blood Culture Positivity nor Time to Positivity Is Associated With Mortality Among Patients Presenting With Severe Manifestations of Sepsis: The FABLED Cohort StudyKatryn Paquette, David Sweet, Robert Stenstrom, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|July 3, 2023
qSOFA does not predict bacteremia in patients with severe manifestations of sepsisMatthew P Cheng, Katryn Paquette, Alexander Lawandi, et al.
Open Forum Infectious Diseases|October 2, 2020
Real-world Time to Positivity of 2 Widely Used Commercial Blood Culture Systems in Patients With Severe Manifestations of Sepsis: An Analysis of the FABLED StudyGuillaume Butler-Laporte, Cedric P Yansouni, Katryn Paquette, et al.
Annals of Internal Medicine|July 5, 2021
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020Sameer S Kadri, Junfeng Sun, Alexander Lawandi, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
Pageof 5